What do analysts expect the price target to be for IMAGENEBIO INC (IMA)?
7 analysts have analysed IMA and the average price target is 16.32 USD. This implies a price increase of 226.4% is expected in the next year compared to the current price of 5.
IMAGENEBIO INC (IMA) Forecast, Price Target & Analyst Ratings
NASDAQ:IMA • US45175G2075
Current stock price
5 USD
0 (0%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IMAGENEBIO INC (IMA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.71
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$16.32
Upside
+ 226.40%
From current price of $5.00 to mean target of $16.32, Based on 7 analyst forecasts
Low
$2.02
Median
$16.32
High
$31.50
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for IMA. The average price target is 16.32 USD. This implies a price increase of 226.4% is expected in the next year compared to the current price of 5.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
77.14%
IMA was analyzed by 7 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about IMA.
In the previous month the buy percentage consensus was at a similar level.
IMA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-10-24 | Leerink Partners | Initiate | Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.71
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 67.10%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
IMA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.71 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 30.99M 237.21% | 15.62M -49.60% | 9.16M -41.36% | -100.00% | 269.337K | -100.00% | 20.705M | 111.1M 436.59% | 226.24M 103.64% | 368.65M 62.95% | ||||
| EBITDA YoY % growth | -33.6M 24.02% | -70.15M -108.78% | -74.397M -6.05% | -89.913M 27.33% | -89.897M -66.28% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -34.14M 23.32% | -70.9M -107.67% | -75.417M -6.37% | -54.035M 27.66% | -73.434M -34.61% | -51.912M 29.31% | -69.026M -32.97% | -112.327M -62.73% | -215.299M -91.67% | -398.216M -84.96% | N/A | N/A | N/A | |
| Operating Margin | -110.16% | -453.91% | -823.33% | N/A | -27,264.60% | N/A | N/A | N/A | N/A | -1,923.28% | N/A | N/A | N/A | |
| EPS YoY % growth | -38.40 | -23.04 40.00% | -20.40 11.46% | -12.00 40.59% | -5.65 41.58% | -3.23 54.35% | -2.89 10.52% | -4.20 -45.29% | -3.56 15.38% | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.71 67.10% | -0.82 -13.91% | -0.42 85.60% | -0.43 66.57% | -0.43 39.37% | -0.43 47.29% | -0.40 4.58% | -0.49 -12.65% | -0.55 -27.90% | -0.57 -32.36% | -0.58 -44.44% | -0.61 -25.68% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | ||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.515M 13.13% | -12.925M -53.13% | -14.266M 46.36% | -15.206M 15.69% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
12.04%
EPS Next 5 Year
10.63%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
138.32%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
IMAGENEBIO INC / IMA Forecast FAQ
Can you provide the upcoming earnings date for IMAGENEBIO INC?
IMAGENEBIO INC (IMA) will report earnings on 2026-05-06, after the market close.
What are the consensus estimates for IMAGENEBIO INC (IMA) next earnings?
The consensus EPS estimate for the next earnings of IMAGENEBIO INC (IMA) is -0.71 USD and the consensus revenue estimate is 0 USD.
Can you provide the expected long term growth rate for IMAGENEBIO INC stock?
The expected long term growth rate for IMAGENEBIO INC (IMA) is -25.99%.